Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Acute Spinal Cord Injury Market In The Coming Years?

The market size for acute spinal cord injury has seen significant expansion in the recent past. A growth projection from $6.7 billion in 2024 to $7.06 billion in 2025 is estimated, with a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this growth during the historic period involve an increase in the occurrence of acute spinal cord injuries, heightened awareness and treatment options for these injuries, a surge in the demand for tailored care, an upturn in disposable income, and increased governmental investment in ASCI research and development.

In the coming years, the market for acute spinal cord injuries is predicted to witness robust growth, with an anticipated size of $8.79 billion by 2029, bearing a compound annual growth rate of 5.6%. The substantial growth projected for this period can be ascribed to factors such as the advent of emerging therapies, the acceptance of telemedicine, patient-centric healthcare models, along with an amplified emphasis on preventive healthcare and injury prevention. The major trends during this forecast period encompass advancements in medical technology, techniques in rehabilitation, neuroprotection therapies as well as advocacy, accessibility, and psychosocial support.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12960&type=smp

Which Growth Drivers Are Shaping The Acute Spinal Cord Injury Market Outlook?

The market for acute spinal cord injuries is predicted to gain momentum due to the rise in road accident occurrences. A road accident is an event where a motor vehicle crash results in severe injuries or even death. Such inadvertent mishaps can damage the central nervous system (CNS), thereby interrupting the nerve communication necessary for functional and sensory abilities. It could lead to trauma in the cervical, lumbar, or thoracic spine due to the accident’s force, affecting or severing the spinal cord and consequently causing paralysis. For instance, in the year 2024, the Llywodraeth Cymru/Welsh Government, an administration based in Wales, reported that in 2023, Welsh police recorded 4,348 road casualties. This figure marked a 2% rise compared to the previous year, 2022. Hence, the escalation in road accidents provides a growth impetus to the acute spinal cord injury market.

What Is The Segment Breakdown Of The Acute Spinal Cord Injury Market?

The acute spinal cord injurymarket covered in this report is segmented –

1) By Type: Complete Spinal Cord Injury; Incomplete Spinal Cord Injury

2) By Diagnosis Type: Laboratory Tests; Imaging Tests

3) By Application: Hospitals; Clinics

Subsegments:

1) By Complete Spinal Cord Injury: Tetraplegia; Paraplegia

2) By Incomplete Spinal Cord Injury: Central Cord Syndrome; Anterior Cord Syndrome; Brown-Séquard Syndrome; Conus Medullaris Syndrome; Cauda Equina Syndrome

What Are The Dominant Trends Currently Seen In The Acute Spinal Cord Injury Market?

In a bid to stay competitive and address customer needs, major firms in the acute spinal cord injury market are turning their focus towards the creation of unique and effective medications. One such promising innovation is the drug LYVISPAH, which has shown potential for improving results when used in combination therapies. In July 2022, Amneal Pharmaceuticals, based in the US, introduced LYVISPAH to the market. This oral granule form of baclofen (available in 5, 10 and 20 mg doses) has been granted approval by the U.S. Food and Drug Administration (FDA) for use in managing spasticity linked to multiple sclerosis and other spinal cord complications. LYVISPAH is designed to treat and alleviate flexor spasms, clonus, associated pain, and muscular rigidity. With its flexible and customizable dosage, presented in single-dose granule packages of 5 mg, 10 mg, and 20 mg, it is just as effective as oral baclofen tablets. Furthermore, it offers potential benefits to patients suffering from spinal cord injuries and other related conditions.

Who Are The Major Stakeholders Operating In The Acute Spinal Cord Injury Market?

Major companies operating in the acute spinal cord injury market are Pfizer Inc., AbbVie Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Biogen Inc., Vertex Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Stanford Health Care, BioMarin Pharmaceutical Inc., Neuralstem Inc., Kennedy Krieger Institute, Acorda Therapeutics Inc., Craig Hospital, Omeros Corporation, Lineage Cell Therapeutics Inc., Pharmazz Inc., Asterias Biotherapeutics Inc., Histocell S.L., Athersys Inc., ReNetX Bio, Kringle Pharma Inc., BioArctic AB, BioAxone BioSciences Inc., InVivo Therapeutics Holdings Corp, Geron Corporation, Neuronax SA, Tenax Therapeutics, Eusol Biotech Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Acute Spinal Cord Injury Market?

North America was the largest region in the acute spinal cord injury market in 2024. The regions covered in acute spinal cord injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=12960&type=smp

Browse Through More Reports Similar to the Global Acute Spinal Cord Injury Market 2025, By The Business Research Company

Spine Implants Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spine-implants-global-market-report

Spinal Cord Stimulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-cord-stimulation-global-market-report

Spinal Imaging Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/spinal-imaging-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model